Priscila Nicolao Mazzola
Universidade Federal do Rio Grande do Sul
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Priscila Nicolao Mazzola.
Metabolic Brain Disease | 2011
Caroline Paula Mescka; Tarsila Barros Moraes; Andrea Pereira Rosa; Priscila Nicolao Mazzola; Bruna Lopes Piccoli; Carlos Eduardo Jacques; Giovana Reche Dalazen; Juliana G. Coelho; Marcelo Xavier Cortes; Melaine Terra; Carmen Regla Vargas; Carlos Severo Dutra-Filho
Maple syrup urine disease (MSUD) is an autosomal recessive inborn error of metabolism caused by deficiency of the activity of the mitochondrial enzyme complex branched-chain α-keto acid dehydrogenase (BCKAD) leading to accumulation of the branched-chain amino acids (BCAA) leucine, isoleucine and valine and their corresponding branched-chain α-keto acids. Affected patients present severe brain dysfunction manifested such as ataxia, seizures, coma, psychomotor delay and mental retardation. The mechanisms of brain damage in this disease remain poorly understood. Recent studies have shown that oxidative stress may be involved in neuropathology of MSUD. L-Carnitine (L-Car) is considered a potential antioxidant through its action against peroxidation as a scavenger of reactive oxygen species and by its stabilizing effect of damage to cell membranes. In this study we evaluate the possible neuroprotective in vivo effects of L-Car against pro-oxidative effects of BCAA in cerebral cortex of rats. L-Car prevented lipoperoxidation, measured by thiobarbituric acid-reactive substances, protein damage, measured by sulfhydryl and protein carbonyl content and alteration on catalase and glutathione peroxidase activity in rat cortex from a chemically-induced model of MSUD. Our data clearly show that L-Car may be an efficient antioxidant, protecting against the oxidative stress promoted by BCAA. If the present results are confirmed in MSUD patients, this could represent an additional therapeutic approach to the patients affected by this disease.
PLOS ONE | 2015
Danique van Vliet; Vibeke M. Bruinenberg; Priscila Nicolao Mazzola; Martijn van Faassen; Pim de Blaauw; Ido P. Kema; M. Rebecca Heiner-Fokkema; Rogier D. van Anholt; Eddy A. Van der Zee; Francjan J. van Spronsen
Background Phenylketonuria (PKU) was the first disorder in which severe neurocognitive dysfunction could be prevented by dietary treatment. However, despite this effect, neuropsychological outcome in PKU still remains suboptimal and the phenylalanine-restricted diet is very demanding. To improve neuropsychological outcome and relieve the dietary restrictions for PKU patients, supplementation of large neutral amino acids (LNAA) is suggested as alternative treatment strategy that might correct all brain biochemical disturbances caused by high blood phenylalanine, and thereby improve neurocognitive functioning. Objective As a proof-of-principle, this study aimed to investigate all hypothesized biochemical treatment objectives of LNAA supplementation (normalizing brain phenylalanine, non-phenylalanine LNAA, and monoaminergic neurotransmitter concentrations) in PKU mice. Methods C57Bl/6 Pah-enu2 (PKU) mice and wild-type mice received a LNAA supplemented diet, an isonitrogenic/isocaloric high-protein control diet, or normal chow. After six weeks of dietary treatment, blood and brain amino acid and monoaminergic neurotransmitter concentrations were assessed. Results In PKU mice, the investigated LNAA supplementation regimen significantly reduced blood and brain phenylalanine concentrations by 33% and 26%, respectively, compared to normal chow (p<0.01), while alleviating brain deficiencies of some but not all supplemented LNAA. Moreover, LNAA supplementation in PKU mice significantly increased brain serotonin and norepinephrine concentrations from 35% to 71% and from 57% to 86% of wild-type concentrations (p<0.01), respectively, but not brain dopamine concentrations (p = 0.307). Conclusions This study shows that LNAA supplementation without dietary phenylalanine restriction in PKU mice improves brain biochemistry through all three hypothesized biochemical mechanisms. Thereby, these data provide proof-of-concept for LNAA supplementation as a valuable alternative dietary treatment strategy in PKU. Based on these results, LNAA treatment should be further optimized for clinical application with regard to the composition and dose of the LNAA supplement, taking into account all three working mechanisms of LNAA treatment.
Metabolic Brain Disease | 2014
Giovana Reche Dalazen; Melaine Terra; Carlos Eduardo Diaz Jacques; Juliana G. Coelho; Raylane Silva de Freitas; Priscila Nicolao Mazzola; Carlos Severo Dutra-Filho
Pipecolic acid (PA) levels are increased in severe metabolic disorders of the central nervous system such as Zellweger syndrome, infantile Refsum disease, neonatal adrenoleukodystrophy and hyperlysinemia. The affected individuals present progressive neurological dysfunction, hypotonia and growth retardation. The mechanisms of brain damage of these disorders remain poorly understood. Since PA catabolism can produce H2O2 by oxidases, oxidative stress may be a possible mechanism involved in the pathophysiology of these diseases. Lipoic acid (LA) is considered an efficient antioxidant and has been shown to prevent oxidative stress in experimental models of many disorders of the neurologic system. Considering that to our knowledge no study investigated the role of PA on oxidative stress, in the present work we investigated the in vitro effects of PA on some oxidative stress parameters and evaluated the LA efficacy against possible pro-oxidant effects of PA in cerebral cortex of 14-day-old rats. The activities of catalase (CAT), glutathione peroxidase (GPx), glucose 6-phosphate dehydrogenase (G6PD), and glutathione S-transferase (GST) along with reduced glutathione (GSH) content were significantly decreased, while superoxide dismutase (SOD) activity and thiobarbituric acid-reactive substances (TBA-RS) were significantly enhanced by PA. LA was able to prevent these effects by improving the activity of antioxidant enzymes, increasing GSH content and reducing TBA-RS. In contrast, glutathione reductase and 6-phosphogluconate dehydrogenase activities and sulfhydryl content were not affected. Taken together, it may be presumed that PA in vitro elicits oxidative stress and LA is able to prevent these effects.
Metabolic Brain Disease | 2013
Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H. Schulpis; Carlos Severo Dutra-Filho
Hyperphenylalaninemia (HPA) leads to increased oxidative stress in patients with phenylketonuria (PKU) and in animal models of PKU. Early diagnosis and immediate adherence to a phenylalanine-restricted diet prevents HPA and, consequently, severe brain damage. However, treated adolescent and adult PKU patients have difficulties complying with the diet, leading to an oscillation of phenylalanine levels and associated oxidative stress. The brain is especially susceptible to reactive species, and oxidative stress might add to the impaired cognitive function found in these patients. The restricted PKU diet has a very limited nutrient content from natural foods and almost no animal protein, which reduces the intake of important compounds. These specific compounds can act as scavengers of reactive species and can be co-factors of antioxidant enzymes. Supplementation with nutrients, vitamins, and tetrahydropterin has given quite promising results in patients and animal models. Antioxidant supplementation has been studied in HPA, however there is no consensus about its always beneficial effects. In this way, regular exercise could be a beneficial addition on antioxidant status in PKU patients. A deeper understanding of PKU molecular biochemistry, and genetics, as well as the need for improved targeted treatment options, could lead to the development of new therapeutic strategies.
Molecular and Cellular Biochemistry | 2015
Andrea Pereira Rosa; Carlos Eduardo Jacques; Laila Oliveira de Souza; Fernanda Hendges de Bitencourt; Priscila Nicolao Mazzola; Juliana Gonzales Coelho; Caroline Paula Mescka; Carlos Severo Dutra-Filho
Abstract Recently, the consequences of diabetes on the central nervous system (CNS) have received great attention. However, the mechanisms by which hyperglycemia affects the central nervous system remain poorly understood. In addition, recent studies have shown that hyperglycemia induces oxidative damage in the adult rat brain. In this regard, no study has assessed oxidative stress as a possible mechanism that affects the brain normal function in neonatal hyperglycemic rats. Thus, the present study aimed to investigate whether neonatal hyperglycemia elicits oxidative stress in the brain of neonate rats subjected to a streptozotocin-induced neonatal hyperglycemia model (5-day-old rats). The activities of glucose-6-phosphate-dehydrogenase (G6PD), 6-phosphogluconate-dehydrogenase (6-PGD), NADPH oxidase (Nox), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSHPx), the production of superoxide anion, the thiobarbituric acid-reactive substances (TBA-RS), and the protein carbonyl content were measured. Neonatal hyperglycemic rats presented increased activities of G6PD, 6PGD, and Nox, which altogether may be responsible for the enhanced production of superoxide radical anion that was observed. The enhanced antioxidant enzyme activities (SOD, CAT, and GSHPx) that were observed in neonatal hyperglycemic rats, which may be caused by a rebound effect of oxidative stress, were not able to hinder the observed lipid peroxidation (TBA-RS) and protein damage in the brain. Consequently, these results suggest that oxidative stress could represent a mechanism that explains the harmful effects of neonatal hyperglycemia on the CNS.
JIMD reports | 2015
Priscila Nicolao Mazzola; Vibeke M. Bruinenberg; Karen Anjema; Danique van Vliet; Carlos Severo Dutra-Filho; Francjan J. van Spronsen; Eddy A. Van der Zee
BACKGROUND High phenylalanine levels in phenylketonuria (PKU) have been associated with brain oxidative stress and amino acid imbalance. Exercise has been shown to improve brain function in hyperphenylalaninemia and neurodegenerative diseases. This study aimed to verify the effects of exercise on coordination and balance, plasma and brain amino acid levels, and brain oxidative stress markers in PKU mice. METHODS Twenty wild-type (WT) and 20 PAH(enu2) (PKU) C57BL/6 mice were placed in cages with (exercise, Exe) or without (sedentary, Sed) running wheels during 53 days. At day 43, a balance beam test was performed. Plasma and brain were collected for analyses of amino acid levels and the oxidative stress parameters superoxide dismutase (SOD) activity, sulfhydryl and reduced glutathione (GSH) contents, total radical-trapping antioxidant potential (TRAP), and total antioxidant reactivity (TAR). RESULTS SedPKU showed poor coordination (p < 0.001) and balance (p < 0.001), higher plasma and brain phenylalanine (p < 0.001), and increased brain oxidative stress (p < 0.05) in comparison to SedWT. ExePKU animals ran less than ExeWT (p = 0.018). Although no improvement was seen in motor coordination and balance, exercise in PKU restored SOD, sulfhydryl content, and TRAP levels to controls. TAR levels were increased in ExePKU in comparison to SedPKU (p = 0.012). Exercise decreased plasma and brain glucogenic amino acids in ExePKU, but did not change plasma and brain phenylalanine in both WT and PKU. CONCLUSIONS Exercise prevents oxidative stress in the brain of PKU mice without modifying phenylalanine levels. Hence, exercise positively affects the brain, demonstrating its value as an intervention to improve brain quality in PKU.
Frontiers in Behavioral Neuroscience | 2016
Vibeke M. Bruinenberg; Els van der Goot; Danique van Vliet; Martijn J. de Groot; Priscila Nicolao Mazzola; M. Rebecca Heiner-Fokkema; Martijn van Faassen; Francjan J. van Spronsen; Eddy A. Van der Zee
To unravel the role of gene mutations in the healthy and the diseased state, countless studies have tried to link genotype with phenotype. However, over the years, it became clear that the strain of mice can influence these results. Nevertheless, identical gene mutations in different strains are often still considered equals. An example of this, is the research done in phenylketonuria (PKU), an inheritable metabolic disorder. In this field, a PKU mouse model (either on a BTBR or C57Bl/6 background) is often used to examine underlying mechanisms of the disease and/or new treatment strategies. Both strains have a point mutation in the gene coding for the enzyme phenylalanine hydroxylase which causes toxic concentrations of the amino acid phenylalanine in blood and brain, as found in PKU patients. Although the mutation is identical and therefore assumed to equally affect physiology and behavior in both strains, no studies directly compared the two genetic backgrounds to test this assumption. Therefore, this study compared the BTBR and C57Bl/6 wild-type and PKU mice on PKU-relevant amino acid- and neurotransmitter-levels and at a behavioral level. The behavioral paradigms were selected from previous literature on the PKU mouse model and address four domains, namely (1) activity levels, (2) motor performance, (3) anxiety and/or depression-like behavior, and (4) learning and memory. The results of this study showed comparable biochemical changes in phenylalanine and neurotransmitter concentrations. In contrast, clear differences in behavioral outcome between the strains in all four above-mentioned domains were found, most notably in the learning and memory domain. The outcome in this domain seem to be primarily due to factors inherent to the genetic background of the mouse and much less by differences in PKU-specific biochemical parameters in blood and brain. The difference in behavioral outcome between PKU of both strains emphasizes that the consequence of the PAH mutation is influenced by other factors than Phe levels alone. Therefore, future research should consider these differences when choosing one of the genetic strains to investigate the pathophysiological mechanism underlying PKU-related behavior, especially when combined with new treatment strategies.
Revista Brasileira De Medicina Do Esporte | 2012
Priscila Nicolao Mazzola; Tarsila Barros Moraes; Carolina Didonet Pederzolli; Andrea Pereira Rosa; Fernanda Rech Zanin; Juliana G. Coelho; Carlos Severo Dutra-Filho
INTRODUCAO: A fenilcetonuria (PKU) e caracterizada pela deficiencia da enzima fenilalanina hidroxilase, causando acumulo de fenilalanina. O diagnostico precoce e a subordinacao a dieta pobre em fenilalanina sao importantes para prevenir os efeitos prejudiciais da hiperfenilalaninemia. Nao aderir estritamente a dieta provoca, entre outros efeitos, um desequilibrio entre os aminoacidos neutros que usam o mesmo transportador da fenilalanina na barreira hematoencefalica, causando, entao, a diminuicao da entrada de triptofano, o precursor de serotonina no cerebro. Esse neurotransmissor tem sido implicado na regulacao dos estados de humor, sendo sua alta producao ligada a fadiga central em individuos submetidos a exercicio prolongado. O exercicio fisico aumenta os niveis de triptofano livre no sangue, o que facilita seu influxo no cerebro, podendo, portanto, ser util nos estados hiperfenilalaninemicos. OBJETIVO: Avaliar se o exercicio aerobico e capaz de normalizar as concentracoes de triptofano no cerebro de ratos com hiperfenilalaninemia. METODOS: Trinta e dois ratos foram separados nos grupos sedentario (Sed) e exercicio (Exe), e cada um deles subdividido em controle (SAL) e hiperfenilalaninemia (PKU). A hiperfenilalaninemia foi induzida pela administracao de alfa-metilfenilalanina e fenilalanina durante tres dias, enquanto os grupos SAL receberam salina. Os grupos Exe realizaram uma sessao de exercicio aerobico com duracao de 60min e velocidade de 12m.min-1. RESULTADOS: A concentracao de triptofano no cerebro nos grupos PKU foi significativamente menor que nos grupos SAL, tanto Sed como Exe, compativel com a condicao hiperfenilalaninemica. O exercicio aumentou a concentracao cerebral de triptofano comparada aos animais sedentarios. O achado mais interessante foi que a concentracao cerebral de triptofano no grupo ExePKU nao foi diferente do SedSAL. CONCLUSAO: Os resultados indicam um importante papel do exercicio aerobico para restaurar a concentracao de triptofano no cerebro em ratos hiperfenilalaninemicos.
Revista Brasileira de Ciências do Esporte | 2014
Marcos Franken; Fabio Carlos Alves Lima; Priscila Nicolao Mazzola; Jocelito Bijoldo Martins; Bruno Costa Teixeira; Carlos Severo Dutra Filho; Flávio Antônio de Souza Castro
The study assessed, at the intensity of 100% of the critical speed (CS), the behavior of blood lactate concentration ([La]), rating of perceived exertion (RPE), heart rate (HR), plasma concentrations of tryptophan [TRP] of prolactin ([PRL]) and free fatty acids ([FFA]). Fourteen swimmers performed two protocols: 1) trials of 200 and 400 m at maximum intensity (V200 and V400) for the CS, 2) CS series (trials of 400 m), and rest intervals of 40 s. The main results were: (1) [TRP] and [FFA] did not differ between rest and exhaustion (p> 0.05), (2) increased [PRL], the [La], HR and RPE (p <0.05) throughout the series CS. Thus the increase in [PRL] may indicate manifestation of central fatigue in intensity corresponding to the CS.
Metabolic Brain Disease | 2011
Priscila Nicolao Mazzola; Melaine Terra; Andrea Pereira Rosa; Caroline Paula Mescka; Tarsila Barros Moraes; Bruna Lopes Piccoli; Carlos Eduardo Jacques; Giovana Reche Dalazen; Marcelo Xavier Cortes; Juliana G. Coelho; Carlos Severo Dutra-Filho
Collaboration
Dive into the Priscila Nicolao Mazzola's collaboration.
Flávio Antônio de Souza Castro
Universidade Federal do Rio Grande do Sul
View shared research outputs